What clinical implications of hypokinesia/bradykinesia are addressed in LSVT BIG treatment?

In the context of LSVT BIG treatment, the clinical implications of hypokinesia and bradykinesia are addressed through the enhancement of motor programming and execution. The focus on weak "get ready, go, and NO go signals" is particularly relevant as it targets the initiation and regulation of movement, which are commonly impaired in individuals with Parkinson's disease and other movement disorders.

By strengthening these signals, LSVT BIG aims to improve the ability of individuals to both initiate movement and halt it when necessary. This is vital because hypokinesia and bradykinesia can lead to difficulties in starting movements, maintaining smooth transitions between movements, and controlling the timing of actions, which can exacerbate mobility issues.

The therapy utilizes cues and strategies that help patients recognize the need to move and to execute movements with more intensity and purpose. This approach aligns with the LSVT BIG principles of facilitating larger, more purposeful movement patterns, ultimately contributing to greater functional mobility and independence.